• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SENTINEL CEREBRAL PROTECTION SYSTEM (US); EMBOLIC PROTECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SENTINEL CEREBRAL PROTECTION SYSTEM (US); EMBOLIC PROTECTION DEVICE Back to Search Results
Model Number CMS15-10C-US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Low Blood Pressure/ Hypotension (1914)
Event Date 01/05/2024
Event Type  Injury  
Event Description
It was reported that a cerebral vascular accident (cva) occurred.The patient was on a periprocedural, anticoagulant medication regimen.A sentinel cerebral protection system (cps) was being used in a radiofrequency, pulmonary vein isolation (pvi) procedure for treatment of paroxysmal atrial fibrillation.The sentinel cps was prepared, inserted, and deployed successfully in its intended location.An intravenous anti-coagulant was given during the procedure.It was noted the patient experienced a short episode of hypotension during pvi ablation related to bradycardia during the ablation.The sentinel cps was removed from the patient upon the conclusion of the procedure.The total procedure time was 4 hours and 14 minutes.The sentinel cps device was implanted for 90 minutes and an additional 10 minutes for removal.One hour after the conclusion of the procedure in the post procedure recovery unit, the patient experienced a second episode of hypotension which was likely attributed to a vagal episode during recovery from anesthesia.It was then noted that neurologic changes occurred, with right upper extremity and left lower extremity weakness.Imaging was performed and revealed the symptoms were related to a cva.In the physician's opinion, the cause of the cva was cerebral hypoperfusion leading to watershed infarcts.This manifested as multiple areas of cortical infarcts in the bilateral hemispheres of the brain and multiple neurological deficits in the patient.The short periods of hypotension experienced by the patient during the procedure combined with the presence of the sentinel cps device in the anterior circulation were the likely etiology of the cva per the physician.The patient was given brain physical rehabilitation and speech therapy and was discharged fourteen (14) days post index procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENTINEL CEREBRAL PROTECTION SYSTEM (US)
Type of Device
EMBOLIC PROTECTION DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18650384
MDR Text Key334648560
Report Number2124215-2024-06083
Device Sequence Number1
Product Code PUM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K192460
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/06/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCMS15-10C-US
Device Catalogue NumberCMS15-10C-US
Device Lot Number0030482840
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/11/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/04/2022
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other;
-
-